CervoMed Inc.
CRVO
$9.01
$0.0951.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.16M | 1.94M | 3.29M | 2.35M | 2.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.16M | 1.94M | 3.29M | 2.35M | 2.49M |
| Cost of Revenue | 7.09M | 5.13M | -- | 2.81M | 2.86M |
| Gross Profit | -4.92M | -3.19M | 3.29M | -467.00K | -364.80K |
| SG&A Expenses | 2.32M | 2.21M | 2.51M | 2.13M | 2.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.40M | 7.34M | 6.28M | 4.94M | 4.97M |
| Operating Income | -7.24M | -5.40M | -3.00M | -2.59M | -2.48M |
| Income Before Tax | -6.71M | -4.75M | -2.32M | -2.51M | -2.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.71M | -4.75M | -2.32M | -2.51M | -2.36M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.71M | -4.75M | -2.32M | -2.51M | -2.36M |
| EBIT | -7.24M | -5.40M | -3.00M | -2.59M | -2.48M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.77 | -0.55 | -0.27 | -0.41 | -0.38 |
| Normalized Basic EPS | -0.48 | -0.34 | -0.17 | -0.25 | -0.24 |
| EPS Diluted | -0.77 | -0.55 | -0.27 | -0.41 | -0.38 |
| Normalized Diluted EPS | -0.48 | -0.34 | -0.17 | -0.25 | -0.24 |
| Average Basic Shares Outstanding | 8.71M | 8.70M | 8.70M | 6.17M | 6.27M |
| Average Diluted Shares Outstanding | 8.71M | 8.70M | 8.70M | 6.17M | 6.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |